Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The EMA at 20: Fernand Sauer reviews the first two decades and offers advice for regulators at all levels

This article was originally published in Scrip

Executive Summary

In January this year, the European Medicines Agency celebrated the 20th anniversary of its creation in 1995. To mark the occasion, Scrip Intelligence and its sister publication Scrip Regulatory Affairs invited a range of individuals and stakeholder bodies to tell us what they think the agency has achieved, and what still remains to be done.

You may also be interested in...



The EMA at 20: Original agency head Fernand Sauer reviews the first two decades and offers advice for regulators at all levels

In January this year, the European Medicines Agency celebrated the 20th anniversary of its creation in 1995. To mark the occasion, Scrip Regulatory Affairs and its sister publication Scrip Intelligence invited a range of key individuals and stakeholder bodies to tell us what they think the agency has achieved, and what still remains to be done.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC027980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel